Showing results (1081-1090 of 1,104) with videos related to
Sort By:
Pageof 111
Cancer Discovery|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune ArchitectureKai Yu, Jianfeng Chen, Yu-Yi Chu, et al.Communications Medicine|May 27, 2026
Polygenic risk score with KLK3 SNP-SNP interaction pairs for predicting prostate cancer aggressivenessHui-Yi Lin, Indrani Sarkar, Harun Mazumder, et al.European Urology|June 29, 2017
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017Silke Gillessen, Gerhardt Attard, Tomasz M Beer, et al.Blood Cancer Journal|June 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE databaseJan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, et al.Nature|June 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapyChristopher P Vellano, Michael G White, Miles C Andrews, et al.Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.European Urology Oncology|June 16, 2019
Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future StudiesTheo H van der Kwast, Jozien Helleman, Daan Nieboer, et al.European Urology|February 1, 2020
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019Silke Gillessen, Gerhardt Attard, Tomasz M Beer, et al.Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.Pageof 111